Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma

Conclusion: The SII is a simple and promising prognostic predictor for patients with surgically resected ESCC. The prognostic value of SII is superior to those of the NLR, PLR and MLR. Moreover, the SII retained prognostic significance in stage I-II ESCC subgroup (OS, DFS) and stage III ESCC subgroup (DFS).

Source: Journal of Cancer - June 13, 2019 Category: Cancer & Oncology Authors: Yibo Gao, Wei Guo, Songhua Cai, Fan Zhang, Fei Shao, Guochao Zhang, Tiejun Liu, Fengwei Tan, Ning Li, Qi Xue, Shugeng Gao, Jie He Tags: Research Paper Source Type: research